πŸ‡ΊπŸ‡Έ FDA
Patent

US 8022094

Carvedilol phosphate

granted A61PA61P9/00A61P9/12

Quick answer

US patent 8022094 (Carvedilol phosphate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P9/00, A61P9/12